ATHIRA PHARMA INC. - COMMON STOCK
0.7300
13-十一月-24 16:45:00
15 分钟延时
股票
-0.0700
-8.75%
今日范围
0.7200 - 0.8100
ISIN
N/A
来源
NASDAQ
-
Athira Pharma Reports Full Year 2022 Financial Results and Recent Pipeline and Business Updates
23 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Present at Upcoming Neuroscience Focused Investor Conferences
08 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
06 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer
31 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Provides 2023 Pipeline Outlook
05 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Publication of Fosgonimeton Preclinical Results in Neurotherapeutics
21 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
05 12月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Host Virtual R&D Event on December 7, 2022, from 2:00 –3:30 pm Eastern time
01 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
28 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
21 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
16 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
10 11月 2022 16:05:04 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Present at Stifel 2022 Healthcare Conference
09 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
07 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
17 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
06 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
15 8月 2022 16:05:02 条件 Nasdaq GlobeNewswire